New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
09:05 EDTCLSN, RIMM, DD, CAT, JNJ, TRV, NUS, VZOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Travelers (TRV), up 3.5%... DuPont (DD), up 0.9%... ALSO HIGHER: Research In Motion (RIMM), up 7.1% after CEO reportedly says may license new BB10 operating system to other companies, upgrade to Outperform at Scotia Capital... Celsion (CLSN), up 11.4% after entering technology development agreement... DOWN AFTER EARNINGS: Verizon (VZ), down 0.9%... Johnson & Johnson (JNJ), down 0.9%... ALSO LOWER: Nu Skin (NUS), down 3.2% after NY Post says Dan Loeb's Third Point took "sizable" short position... Caterpillar (CAT), down 1.8% after announcing plans for $580M Q4 charge for accounting misconduct at unit.
News For TRV;DD;VZ;JNJ;RIMM;NUS;CAT;CLSN From The Last 14 Days
Check below for free stories on TRV;DD;VZ;JNJ;RIMM;NUS;CAT;CLSN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 15, 2014
06:32 EDTJNJPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
05:29 EDTTRVTravelers downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
April 14, 2014
15:17 EDTJNJNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.48; Coca-Cola (KO), consensus 44c; Charles Schwab (SCHW), consensus 22c; Northern Trust (NTRS), consensus 78c; Comerica (CMA), consensus 72c; Westamerica (WABC), consensus 58c; Comverse (CNSI), consensus 49c; Pep Boys (PBY), consensus 5c.
13:25 EDTJNJEarnings Preview: J&J looking for another strong performance in pharmaceuticals
Subscribe for More Information
10:02 EDTJNJOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTVZT-Mobile CEO starts petition for consumers to call on peers to end overages
Subscribe for More Information
09:05 EDTVZT-Mobile abolishes consumer overages, challenges other providers to follow suit
T-Mobile (TMUS) announced a campaign to eliminate overage penalties, one of the most reviled wireless industry practices. While abolishing overages for all customers on T-Mobile consumer plans, its CEO has also laid down a challenge to the nation's largest carriers, AT&T (T), Verizon (VZ) and Sprint (S), to do the same.
07:06 EDTVZU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
05:56 EDTJNJJohnson & Johnson downgraded to Hold from Buy at Jefferies
Jefferies downgraded its rating on Johnson & Johnson (JNJ) to Hold citing the recent outperformance of shares. The firm keeps a $105 price target for the stock.
April 11, 2014
18:44 EDTJNJJ&J halting development of Botox competitor, WSJ says
Subscribe for More Information
15:54 EDTNUSNu Skin puts active after FT reports Herbalife facing criminal investigation
Subscribe for More Information
15:45 EDTNUSUsana, Nu Skin on lows after FT reports Herbalife facing criminal investigation
Subscribe for More Information
09:19 EDTVZANADIGICS ships AWC6383 dual-band ProVantage PA to Samsung
Subscribe for More Information
07:26 EDTVZTime Warner struggling to force Dodgers network on pay-TV players, LAT say
Subscribe for More Information
April 9, 2014
12:04 EDTDDU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
11:15 EDTVZT-Mobile unveils $40 monthly price plan called 'Simple Starter'
Subscribe for More Information
09:33 EDTCATBofA/Merrill's industrial/mining analysts hold analyst/industry conference call
Subscribe for More Information
08:03 EDTCLSNCelsion announces data supporting development of ThermoDox
Celsion announced that data supporting the development of ThermoDox, its proprietary heat-activated liposomal encapsulation of doxorubicin, plus high intensity focused ultrasound were presented at the International Symposium on Therapeutic Ultrasound. Mark Dewhirst, D.V.M., Ph.D. presented data demonstrating the potential of ThermoDox plus HIFU to maximize drug delivery to the targeted tumor site. Celsion is exploring the potential of ThermoDox in combination with HIFU as a non-invasive treatment for a variety of cancers, including pancreatic cancer, Glioblastoma Multiforme, metastatic liver cancer, and breast cancer.
07:23 EDTJNJEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
07:09 EDTJNJJohnson & Johnson outlook positive into Q1 results, says Bernstein
Bernstein expects Johnson & Johnson's Q1 EPS to come in slightly above the consensus estimate, with strength in pharmaceuticals more than offsetting lackluster Medical Devices & Diagnostics growth, according to the firm. Bernstein keeps an Outperform rating on the stock.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use